Policy & Patient Affairs Manager R&I and CVRM AstraZeneca

Do you have outstanding experience in the market access field of policy shaping and patient affairs and want to work for a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the company for you!

As part of AstraZeneca, the Nordic Marketing Company (Nordic) employs around 400 people across 5 countries with offices located in Södertälje, Copenhagen, Helsinki and Oslo. By 2025 AstraZeneca Nordic aims to become a recognized leader in its core therapy areas and improve the lives of millions of people. This will be achieved by driving innovative science, preparing launches, building close collaborations and partnerships with stakeholders in health care systems, and developing high-performing teams.

The role

The Policy & Patient Affairs Manager for the BBU (Biopharmaceutical Business Unit) is accountable for developing and implementing national policy shaping strategies and plans to support both the R&I (Respiratory & Immunology) and CVRM (Cardiovascular-Renal-Metabolism) therapy areas.  Additionally, the Policy & Patient Affairs Manager will manage the ongoing relationships with National Patient Organizations and in collaboration with patient groups, develop and implement projects.  The Policy & Patient Affairs Manager will work closely with cross-functional teams across medical, marketing and sales to ensure alignment to strategy and strong execution.

This role reports to the GAMA Head, Sweden and is located in the Södertälje office.

Accountabilities

  • Lead policy shaping activities such as Act on HF, Act on CKD, Act on COPD
  • Lead cross-functional team in development and execution of strategic plan
  • Work closely with Global to ensure alignment to Global strategies and integration of best practices
  • Establish relevant KPIs and ensure successful attainment
  • Lead prioritized Ecosystem Projects to support patient journey such as HF Ecosystem and OCS Ecosystem
  • Lead cross-functional team in development and execution of strategic plan
  • Gather robust insights to drive strategy
  • Establish relevant KPIs and ensure successful attainment
  • Participate in Franchise Teams (Inhaled, Bio, CVRM) and project teams as needed
  • Manage AZ relationship with Patient Groups such as: Lupus, Asthma/Lung, Diabetes, Kidney, Heart

 

Essential Qualifications

At AstraZeneca, we’re driven by innovation and our commitment to make a real-life difference in patients’ lives. That difference starts with you!

  • Strong understanding of Sweden market access, pricing and healthcare process
  • Strategic thinking – able to consider both long term and short term
  • Excellent project leadership skills
  • Proven ability interacting with and influencing stakeholders
  • Previous experience in working with Patient Organizations
  • Strong communication & ability to collaborate effectively accross functions – both internally and externally
  • Entrepreneurial approach to problem solving/innovative in developing creative solutions
  • Able to synthesize insights to formulate strategies
  • Pharmaceutical experience in primary care
  • Good scientific understanding
  • High performer and results oriented with proven results

 

Desirable Qualifications

  • Previous exposure and/or experience in other functional areas of the business such as Sales, Marketing, Medical, Market Access or Health Economics
  • Experience in CVRM/R&I therapy area

 

Why AstraZeneca

At AstraZeneca, we turn ideas into life changing medicines and strive to continuously meet the unmet needs of patients worldwide. Working here means being entrepreneurial, thinking big and working together, to make the impossible a reality!

Are you ready to bring new ideas and fresh thinking to the table? Brilliant!

Apply to us:

Leif Olsson, leif.olsson@hpsearch.se, m: +46 (0)70 699 47 80 or Catharina Bergold, Catharina.bergold@hpsearch.se m: +46 (0)70 217 98 79 or Nina Fredriksson, nina.fredriksson@hpsearch.se, m: +46 (0)73 243 87 02.

We look forward to your application no later than December 16.